Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An extremely rare, aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the liver.
Biomarker and diagnostic research for liver neuroendocrine carcinoma has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
173 publications have been identified in PubMed for liver neuroendocrine carcinoma. Kisho has analyzed 109 by research type. Research spans Review / Meta-Analysis (50%), Basic Science / Preclinical (17%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 54 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 19 | 17% |
Patient case studies | 16 | 15% |
Testing and diagnosis research | 8 | 7% |
Clinical study results | 8 | 7% |
Disease patterns and progression | 3 | 3% |
New treatment approaches | 1 | 1% |
Lahner E (2026). [PMID: 41198445](https://pubmed.ncbi.nlm.nih.gov/41198445/). *Dig Liver Dis*. [Review / Meta-Analysis]
Yin S (2026). [PMID: 41942803](https://pubmed.ncbi.nlm.nih.gov/41942803/). *Discov Oncol*. [Case Report / Case Series]
Yeon KD (2026). [PMID: 41751107](https://pubmed.ncbi.nlm.nih.gov/41751107/). *Animals (Basel)*. [Case Report / Case Series]
Fanburg-Smith JC (2026). [PMID: 41455220](https://pubmed.ncbi.nlm.nih.gov/41455220/). *Semin Diagn Pathol*. [Review / Meta-Analysis]
Ataka R (2026). [PMID: 41712531](https://pubmed.ncbi.nlm.nih.gov/41712531/). *Am J Case Rep*. [Case Report / Case Series]
Fu Z (2026). [PMID: 41512870](https://pubmed.ncbi.nlm.nih.gov/41512870/). *Cancer Cell*. [Basic Science / Preclinical]
Arends MJ (2026). [PMID: 41724188](https://pubmed.ncbi.nlm.nih.gov/41724188/). *Histopathology*. [Review / Meta-Analysis]
Perez K (2026). [PMID: 40344544](https://pubmed.ncbi.nlm.nih.gov/40344544/). *JCO Oncol Pract*. [Review / Meta-Analysis]
Hu H (2026). [PMID: 41578491](https://pubmed.ncbi.nlm.nih.gov/41578491/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Wang WT (2026). [PMID: 41679248](https://pubmed.ncbi.nlm.nih.gov/41679248/). *Mol Aspects Med*. [Review / Meta-Analysis]